Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Bei Raumtemperatur und auerhalb der Reichweite von Kindern aufbewahren
Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials
Mounjaro Mounjaro, developed by Eli Lilly and Company, is a once-weekly injectable that combines the effects of two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
Eating Less Food Food naturally provides water and electrolytes
The placebo group (discontinuation group) regained 6.9% of body weight over 48 weeks, while the continuation group lost an additional 7.9%
US$ 20.52
US$ 23.60
US$ 20.68
US$ 28.57
